AAF Wealth Management’s Q32 Bio QTTB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-2,639
Closed -$48.9K 51
2023
Q1
$48.9K Hold
2,639
0.03% 46
2022
Q4
$59.9K Hold
2,639
0.04% 43
2022
Q3
$76.5K Hold
2,639
0.06% 38
2022
Q2
$93.6K Hold
2,639
0.07% 36
2022
Q1
$144K Hold
2,639
0.09% 31
2021
Q4
$173K Hold
2,639
0.13% 25
2021
Q3
$374K Sell
2,639
-683
-21% -$87K 0.28% 17
2021
Q2
$435K Hold
3,322
0.34% 16
2021
Q1
$563K Hold
3,322
0.48% 12
2020
Q4
$675K Buy
+3,322
New +$642K 0.61% 12

Other funds holding QTTB

AAF Wealth Management's QTTB Position: Q2 2023 in Review

AAF Wealth Management sold out of Q32 Bio (QTTB) in Q2 2023, closing a stake of 2,639 shares — an estimated $48.9K sold.

AAF Wealth Management first reported a position in QTTB in Q4 2020 and held it in 10 quarters. The position peaked at $675K in Q4 2020. 59 funds tracked by Wall St. Rank hold QTTB as of Q2 2023.

  • AAF Wealth Management reported no remaining Q32 Bio position as of Q2 2023 after selling out during the quarter.
  • AAF Wealth Management sold 2,639 Q32 Bio shares in Q2 2023, an estimated $48.9K.
  • AAF Wealth Management first reported a position in Q32 Bio in Q4 2020 and held it in 10 quarters.
  • AAF Wealth Management's Q32 Bio position peaked at $675K in Q4 2020.
  • 59 funds tracked by Wall St. Rank held Q32 Bio as of Q2 2023.

Based on AAF Wealth Management's 13F filing for Q2 2023, filed 10 Aug 2023.